This editorial accompanies an original research article by Dr Elzein and colleagues describing findings of a randomized, placebo-controlled trial of nitric oxide administration during cardiopulmonary bypass surgery in infants undergoing the Norwood procedure.
Get full access to this article
View all access options for this article.
References
1.
ElzeinCUrbasCHughesBLiYLefaiverCIlbawiMVricellaL. Efficacy of nitric oxide administration in attenuating ischemia/reperfusion injury during neonatal cardiopulmonary bypass. World J Pediatr Congenit Heart Surg. 2020;11(4):417–423.
2.
PaparellaDYauTMYoungE. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg. 2002;21(2):232–244.
3.
BennettMThuysCAugustinS, et al.The safe addition of nitric oxide into the sweep gas of the extracorporeal circuit during cardiopulmonary bypass and extracorporeal life support. J Extra Corpor Technol. 2018;50(4):260–264.
ShaefiSMittelAKlickJ, et al.Vasoplegia after cardiovascular procedures-pathophysiology and targeted therapy. J Cardiothorac Vasc Anesth. 2018;32(2):1013–1022.
6.
EngelmanDTWatanabeMEngelmanRM, et al.Constitutive nitric oxide release is impaired after ischemia and reperfusion. J Thorac Cardiovasc Surg. 1995;110(4 pt 1):1047–1053.
7.
SpinaSLeiCPinciroliRBerraL. Hemolysis and kidney injury in cardiac surgery: the protective role of nitric oxide therapy. Semin Nephrol. 2019;39(5):484–495.
8.
SardoSOsawaEAFincoG, et al.Nitric oxide in cardiac surgery: a meta-analysis of randomized controlled trials. J Cardiothorac Vasc Anesth. 2018;32(6):2512–2519.
9.
LeiCBerraLRezoagliE, et al.Nitric oxide decreases acute kidney injury and stage 3 chronic kidney disease after cardiac surgery. Am J Respir Crit Care Med. 2018;198(10):1279–1287.
LangJDJrSmithABBrandonA, et al.A randomized clinical trial testing the anti-inflammatory effects of preemptive inhaled nitric oxide in human liver transplantation. PLoS One. 2014;9(2):e86053.
12.
BolliR. Cardioprotective function of inducible nitric oxide synthase and role of nitric oxide in myocardial ischemia and preconditioning: an overview of a decade of research. J Mol Cell Cardiol. 2001;33(11):1897–1918.
13.
ChecchiaPABronickiRAMuenzerJT, et al.Nitric oxide delivery during cardiopulmonary bypass reduces postoperative morbidity in children—a randomized trial. J Thorac Cardiovasc Surg. 2013;146(3):530–536.
14.
JamesCMillarJHortonSBrizardCMolesworthCButtW. Nitric oxide administration during paediatric cardiopulmonary bypass: a randomised controlled trial. Intensive Care Med. 2016;42(11):1744–1752.
15.
GianettiJDel SartoPBevilacquaS, et al.Supplemental nitric oxide and its effect on myocardial injury and function in patients undergoing cardiac surgery with extracorporeal circulation. J Thorac Cardiovasc Surg. 2004;127(1):44–50.
16.
SchlapbachLJHortonSBLongDA, et al.Study protocol: NITric oxide during cardiopulmonary bypass to improve Recovery in Infants with Congenital heart defects (NITRIC trial): a randomised controlled trial. BMJ Open. 2019;9(8):e026664.
17.
GrahamEM. The utility of steroids in pediatric cardiac operations. Pediatr Crit Care Med. 2014;15(5):492–493.
18.
GrahamEMAtzAMMcHughKE, et al.Preoperative steroid treatment does not improve markers of inflammation after cardiac surgery in neonates: results from a randomized trial. J Thorac Cardiovasc Surg. 2014;147(3):902–908.
19.
HillKDBaldwinHSBichelDP, et al.Rationale and design of the STeroids to REduce systemic inflammation after infant heart Surgery (STRESS) trial. Am Heart J. 2019;220:192–202.
20.
FelkerGMMaiselAS. A global rank end point for clinical trials in acute heart failure. Circ Heart Fail. 2010;3(5):643–646.
